You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 250 No. 8, August 26, 1983 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BENCH AND BEDSIDE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human T-Cell Leukemia-Lymphoma Virus and Adult T-Cell Leukemia

William A. Blattner, MD; Kiyoshi Takatsuki, MD; Robert C. Gallo, MD

JAMA. 1983;250(8):1074-1080.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ISOLATION and characterization of the human T-cell leukemia-lymphoma virus (HTLV)1-5 and its relationship to adult T-cell leukemia (ATL)6-8 represent the remarkable convergence of scientific discoveries made half a world apart. The discovery of HTLV represents the culmination of a search for a true human retrovirus (type C virus) that dates back more than 50 years. Almost simultaneous to this breakthrough was the remarkable recognition of a distinctive clinicopathologic entity, ATL.9-11 The molecular and clinical studies summarized in this review represent a scientific tale of two cities, Bethesda, Md, and Kyoto, Japan.

HTLV: A Prototype Human Retrovirus

In numerous animal species, naturally occurring leukemias or lymphomas are caused by retroviruses (also known as type C viruses, RNA tumor viruses, leukemia viruses).12-14 This class of virus is characterized by a replication cycle requiring integration of the viral genetic material in the form of a provirus into host . . . [Full Text PDF of this Article]


Author Affiliations

From the Environmental Epidemiology Branch (Dr Blattner) and the Laboratory of Tumor Cell Biology (Dr Gallo), National Cancer Institute, Bethesda, Md; and the Second Department of Internal Medicine, Kumamoto University, Kumamoto, Japan (Dr Takatsuki).


Footnotes

Reprint requests to Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20205 (Dr Gallo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.